Hypertension
Hypertension, or high blood pressure, is a chronic condition where the blood pressure in the arteries is consistently elevated, often due to an unhealthy lifestyle or other medical conditions. While it typically shows no symptoms, it significantly increases the risk of severe health issues such as stroke, heart disease, and chronic kidney disease, making it a leading cause of premature death globally.
Health Outcomes
- Activation of G-Protein Coupled Receptors
- Altered Catecholamine Level
- Attenuated Blood Pressure (Inactivated Cells Only)
- Change in Waist-to-Hip Ratio
- Delayed Cardiac Pathology
- Disease Prevention
- Elevated Plasma-Branched Chain Amino Acids
- Elevated Redox Status
- Elevated Serum Leptin Levels
- Endothelial Cell Damage
- Enhanced AMPK Activation
- Enhanced Antioxidant Bioaccessibility
- Enhanced Folate Synthesis
- Enhanced Health Promotion in Disease Management
- Enhanced Nitric Oxide Production
- Enhanced Polyphenol Levels
- Enhanced Survival Under Stress
- Extended Lifespan
- Identified ACE-Inhibitory Peptides
- Improved Adherence Ability
- Improved Aerobic Endurance Performance
- Improved Aerobic Power
- Improved Aerobic Stability
- Improved Aging-Related Changes
- Improved Antihypertensive Activity
- Improved Antioxidant Capacity
- Improved Antioxidant Levels
- Improved Antioxidative Capacity
- Improved Arginine Metabolism
- Improved Atherosclerosis-Related Cardiovascular Risk Markers
- Improved Bioactivity
- Improved Biochemical Parameters
- Improved Blood Biochemical Indicators
- Improved Blood Biochemical Markers
- Improved Blood Clinical Chemistry
- Improved Blood Parameters
- Improved Blood Pressure
- Improved Cardiac Baroreflex Sensitivity
- Improved Cardiometabolic Health
- Improved Cardiometabolic Score
- Improved Cardioprotective Activity
- Improved Cardiovascular Disease Marker
- Improved Cardiovascular Disease Outcomes
- Improved Cardiovascular Function
- Improved Cardiovascular Health
- Improved Cerebral Blood Flow
- Improved Dialysis Adequacy
- Improved Diastolic Function
- Improved Diet Quality Index
- Improved Disease Management
- Improved Dyslipidemia
- Improved Efficacy Rate
- Improved Endothelial Function Biomarker
- Improved Endothelial Health Marker Level
- Improved Endothelial Reactivity
- Improved Endothelium-Dependent Vasodilation
- Improved Endothelium-Dependent Vasodilation in Resistance Arteries
- Improved Endothelium-Independent Microvascular Vasodilation
- Improved Fish Chemical Composition
- Improved Flow-Mediated Dilation
- Improved Flow-Mediated Vasodilation
- Improved Functional Properties of Food
- Improved General Health
- Improved General Health Perception
- Improved Health Condition
- Improved Health Markers
- Improved Health Outcomes
- Improved Health Promotion
- Improved Health Status
- Improved Health Status Score
- Improved Health in Elderly Populations
- Improved Heart Rate Variability
- Improved High-Intensity Intermittent Exercise Performance
- Improved Homeostasis
- Improved Human Health
- Improved LDL Cholesterol
- Improved Lifespan
- Improved Longevity
- Improved Maximal Oxygen Uptake
- Improved Mean Arterial Pressure
- Improved Medication Adherence
- Improved Metabolic Activity of Bacillus coagulans
- Improved Metabolic Disease Markers
- Improved Metabolic Function
- Improved Metabolic Health
- Improved Metabolic Parameters
- Improved Metabolic Profile
- Improved Metabolic Regulation
- Improved Metabolic Syndrome Biomarkers
- Improved Metabolic Syndrome Remission
- Improved Microvascular Vasodilation
- Improved Myocardial Strain Rate
- Improved Neurofibromatosis
- Improved Obesity Metrics
- Improved Obesity Parameters
- Improved Overall Health
- Improved Overall Health Status
- Improved Oxidative Metabolism Regulation
- Improved Oxidative Stress Levels
- Improved Oxidative Stress Marker
- Improved Parasympathetic Activity
- Improved Patient Satisfaction
- Improved Peroxisome Proliferator-Activated Receptor Gamma Expression
- Improved Physical Activity Initiation
- Improved Physical Activity Level
- Improved Physiological Parameters
- Improved Post-Myocardial Infarction Outcome
- Improved Prognosis of Type 2 Diabetes Mellitus
- Improved Proportion of Healthy Days
- Improved Reactive Hyperemia Index
- Improved Retinal Microvascular Caliber
- Improved Retinal Vascular Health
- Improved Retinopathy
- Improved Safety in Pregnant Women
- Improved Serum Antioxidant Capacity
- Improved Serum Averages
- Improved Serum SOD Activity
- Improved Small Vessel Density
- Improved Stress Management
- Improved Stress-Strain Index
- Improved Superoxide Dismutase Level
- Improved Sympathetic Tone
- Improved Systemic Health
- Improved Systemic Metabolism
- Improved Total Antioxidant Status
- Improved Treatment Compliance
- Improved Treatment Efficacy
- Improved Treatment Success
- Improved VO2 Max
- Improved VO2max
- Improved Vascular Endothelial Function
- Improved Vascular Function
- Improved Vascular Function in Offspring
- Improved Vasodilation
- Improved Waist-to-Hip Ratio
- Improved Weight Control
- Improved Weight Management
- Improved n-6 to n-3 PUFA Ratio
- Increased ACE Inhibitor Activity
- Increased Adiponectin Levels
- Increased Antihypertensive Peptide Production
- Increased Arginine/ADMA Ratio
- Increased Bioactivity
- Increased Blood Pressure
- Increased Body Mass
- Increased Body Mass Index
- Increased Body Weight
- Increased C-Reactive Protein Levels
- Increased Catalase Activity
- Increased Circulating Nitric Oxide Level
- Increased Endogenous Acrolein Formation
- Increased Endothelial Nitric Oxide Synthase Activity
- Increased F2-Isoprostane Level
- Increased General Morbidity
- Increased Headache
- Increased Hypothalamic Expression of Pro-inflammatory Markers
- Increased Longevity
- Increased Milk Alpha-Carotene Concentration
- Increased Nattokinase Activity
- Increased Nitrate Level
- Increased Nitric Oxide Bioavailability
- Increased Nitric Oxide Metabolite Levels in Metabolic Syndrome Patients
- Increased Nitric Oxide Synthase Activity
- Increased Physical Activity
- Increased Plasma Nitric Oxide Levels
- Increased Plasminogen Activator Inhibitor-1 Level
- Increased Polyphenol Level
- Increased Production of ACE-Inhibitory Peptides
- Increased Production of Bioactive Peptides
- Increased Production of Bioactive Peptides with Angiotensin Converting Enzyme Inhibitory Activity
- Increased Proportion of Healthy Days
- Increased Reactive Oxygen Species Response
- Increased SalA-like Inhibitory Activity
- Increased Serum High-Molecular Weight Adiponectin
- Increased Shear Force
- Increased Soluble Receptor of Advanced Glycation End Products
- Increased Soluble Vascular Cell Adhesion Molecule-1 Level
- Increased Survival in High Osmotic Pressure
- Increased Systolic Blood Pressure
- Increased Total Thiol Level
- Increased Treatment Effectiveness
- Increased Tyramine Production
- Increased VO2 Max
- Increased Visceral Fat Mass
- Increased n-3 Polyunsaturated Fatty Acid Levels
- Induced Health-Related Benefits
- Maintained Clinical Safety Parameters
- Maintained General Health
- Maintained Homeostasis
- Maintained Physical Activity Level
- Mitigated Adverse Physiological Processes
- Multiple Health-Promoting Effects
- No Adverse Safety Findings
- No Change in Body Weight or Cardiometabolic Parameters
- No Change in Major Cardiovascular Event
- No Difference in Adverse Events
- No Reduction in Meat Cholesterol Levels
- No Significant Change in Blood Pressure
- No Significant Weight Change
- No Sustained Protective Effect
- Normalization of Blood Biochemical Parameters
- Notable Improvement in Multiple Health Metrics
- Preserved Cardiac Function
- Prevention of Cardiovascular Diseases
- Reduced 8-Isoprostane Level
- Reduced ACE Activity
- Reduced Abdominal Adiposity
- Reduced Abdominal Visceral Fat
- Reduced Adherence Attrition
- Reduced Advanced Glycation End Product Level
- Reduced Adverse Physiometabolic Effects
- Reduced Age-Related Inflammation
- Reduced Anger and Hostility
- Reduced Angiotensin I-Converting Enzyme Activity
- Reduced Aortic Superoxide Levels
- Reduced Aortic Thickness
- Reduced Apelin Gene Expression
- Reduced Arterial Stiffness
- Reduced Atherosclerosis
- Reduced Atherosclerosis Risk Factors
- Reduced Atrial Fibrillation Risk
- Reduced Augmentation Index
- Reduced Blood Parameters Post Lead Exposure
- Reduced Blood Pressure
- Reduced Blood Pressure in Offspring
- Reduced Body Fat
- Reduced Carboxymethyl Lysine
- Reduced Cardiac Hypertrophy
- Reduced Cardiac Injury
- Reduced Cardiovascular Disease Mortality
- Reduced Cardiovascular Disease Risk
- Reduced Cardiovascular Dysfunction
- Reduced Cardiovascular Event
- Reduced Cardiovascular Mortality
- Reduced Cardiovascular Risk
- Reduced Cardiovascular Risk Profile
- Reduced Catalase Activity
- Reduced Central Blood Pressure
- Reduced Central Systolic Blood Pressure
- Reduced Cerebral Blood Flow
- Reduced Cerebral Blood Flow Velocity
- Reduced Cerebrovascular Disease Mortality
- Reduced Community Healthcare Costs
- Reduced Conicity Index
- Reduced Contrast-Induced Acute Kidney Injury
- Reduced Cumulative Morbidity Rates
- Reduced Cumulative Mortality
- Reduced Dietary Advanced Glycation End Product Intake
- Reduced F2-Isoprostanes
- Reduced Flavonoid Levels
- Reduced Healthcare Costs
- Reduced Heart Failure
- Reduced Heart Rate Variability
- Reduced Hospitalization Requirement
- Reduced Hydrogen Sulfide Level
- Reduced Hydroperoxide Levels
- Reduced Hypercholesterolemia Incidence
- Reduced Incidence of Cardiovascular Disease
- Reduced Insulin Sensitivity
- Reduced Intrauterine Fetal Demise
- Reduced Ischemic Heart Disease Mortality
- Reduced Ischemic Stroke Mortality
- Reduced Lead Bioaccumulation
- Reduced Lead Toxicity
- Reduced Maternal Mortality
- Reduced Maternal and Neonatal Composite Outcome
- Reduced Medication Requirement
- Reduced Metabolic Disease Risk
- Reduced Metabolic Syndrome
- Reduced Morbidity Rate
- Reduced Mortality Rate under Stress
- Reduced Mortality Risk
- Reduced NSAID Consumption
- Reduced Nitric Oxide Level
- Reduced Nitric Oxide Production
- Reduced Non-Communicable Disease Risk
- Reduced Non-Infectious Complication Morbidity
- Reduced Non-Programmed Medical Visits
- Reduced Obesity Indicators
- Reduced Obesity-Related Taxa
- Reduced Omission Errors
- Reduced Overall Complication
- Reduced Oxidative Stress
- Reduced Oxidative Stress Index
- Reduced Oxidative Stress Marker Level
- Reduced Perinatal Loss
- Reduced Pre-eclampsia
- Reduced Preterm Birth Rate
- Reduced Preterm Births
- Reduced Protein Oxidation
- Reduced Rate of Preterm Births Under 34 Weeks
- Reduced Renal Hypertrophy
- Reduced Renal Sympathetic Activity
- Reduced Risk of COVID-19 Progression
- Reduced Risk of Coronary Heart Disease
- Reduced Risk of Diabetes
- Reduced Risk of Preeclampsia
- Reduced Sagittal Abdominal Diameter
- Reduced Serum 8-isoprostane Concentrations
- Reduced Standard Care Medication Need
- Reduced Stillbirth
- Reduced Stroke Mortality Risk
- Reduced Sugar-Sweetened Beverage Intake
- Reduced Sympathetic Hyperactivity
- Reduced Symptoms Associated with High-Fat Diet
- Reduced Systolic Blood Pressure
- Reduced TMAO Production
- Reduced Triglyceridemia
- Reduced Type 2 Diabetes Symptoms
- Reduced Urinary Albumin
- Reduced Urinary Nitrite Level
- Reduced Vascular Damage
- Reduced Vascular Permeability
- Reduced Vascular Stiffness
- Reduced Visceral Fat
- Reduced Visceral Fat Accumulation
- Reduced Visfatin Level
- Reduced Waist Circumference
- Reduced Waist-to-Height Ratio
- Regulated Blood Pressure
- Remission of Metabolic Syndrome
- Restoration of Homeostasis
- Safe Administration
- Safe for Chronic Consumption
- Safety During Pregnancy
- Stabilized Physiological Stress Markers
- Stabilized Visceral Fat Area
- Suppressed PPAR/SREBP Pathway Gene Activity
- Unchanged Monocyte Chemoattractant Protein-1 Levels